HMGB3 and breast carcinoma: It should be noted that recent studies of breast cancer have shown that, along with PTMs characteristic of almost all protein molecules, there is a missense mutation in HMGB3 that involves the replacement of Lys with Asn in positions 30 and 155 [107].